id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
bjp-24149	Peng, Nai-Xiong; Liu, Chun-Xiao; Wang, Xi-Sheng; Zhang, Ze-Jian; Liao, Su-Cai	Combination of axitinib and dasatinib for anti-cancer activities in two prostate cancer cell lines	2015	10	.pdf	application/pdf	4541	222	55	Axitinib and dasatinib combination lowered the survival rate of PPC-1 cells but enhanced the survival rate of TSU-Pr1 cells. 48 and 72 hours after administration of 20 mM of the equimolar concentration of axitinib and dasatinib, the viability of PPC-1 cells significantly decreased to 88 and 82% respectively (Figure 1).	cache/bjp-24149.pdf	txt/bjp-24149.txt